Flomics COVID-19 NGS platform

Flomics has joined forces with international biotech partners, specialized in Next Generation Sequencing tests, to develop a cloud-based data analysis solution for COVID19 detection and research. Combining the unique features of the different experimental sequencing kits available for SARS-CoV-2 detection (either metagenomics or ampicon based), we maximize the information extracted from each single experiment performed in a reliable, sensitive and automated way.

Our platform helps hospitals, clinics and research laboratories in transforming raw data  into interpretable clinical information that will help manage this pandemic, without the need for computational infrastructures or bioinformatics expertise